Polypharmacy and Health-Related Quality of Life/Psychological Distress Among Patients With Chronic Disease.

ABSTRACT:

Introduction

To date, no study has investigated the impact of polypharmacy (use of ≥5 medications concurrently) on health-related quality of life (HRQOL) and psychological distress in a combined sample of chronic disease patients and patients with multimorbidity, using diverse HRQOL measures. This study aimed to explore the association between polypharmacy and HRQOL/psychological distress by using data from a cross-sectional study in Flanders (Belgium).

Methods

We analyzed cross-sectional survey data on 544 chronically ill patients recruited from June 2019 through June 2021. HRQOL was measured with the EuroQol-5 Dimension-5 Level questionnaire (EQ-5D-5L) and the 12-Item Short Form Health Survey (SF-12); psychological distress was measured with the Hospital Anxiety and Depres

SUBMITTER: Van Wilder L 

PROVIDER: S-EPMC9390791 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature